|
BG16042A3
(bg)
*
|
1968-11-12 |
1972-05-20 |
Nans Ott |
Метод за получаване на нови 2(1н)-хиназолинони
|
|
AU543928B2
(en)
|
1981-01-16 |
1985-05-09 |
Masayuki Ishikawa |
4(311)-quinazolinone derivatives
|
|
US4522811A
(en)
*
|
1982-07-08 |
1985-06-11 |
Syntex (U.S.A.) Inc. |
Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
|
|
US5187167A
(en)
*
|
1986-03-27 |
1993-02-16 |
Imperial Chemical Industries Plc |
Pharmaceutical compositions comprising quinazolin-4-one derivatives
|
|
GB8707053D0
(en)
*
|
1987-03-25 |
1987-04-29 |
Ici Plc |
Anti-tumour agents
|
|
NZ227850A
(en)
*
|
1988-02-10 |
1991-11-26 |
Hoffmann La Roche |
Indole substituted pyrrole derivatives; preparatory process and medicaments for use against inflammatory immunological, bronchopulmonary or vascular disorders
|
|
GB8827820D0
(en)
*
|
1988-11-29 |
1988-12-29 |
Janssen Pharmaceutica Nv |
(1h-azol-1-ylmethyl)substituted quinoline derivatives
|
|
GB8827988D0
(en)
*
|
1988-11-30 |
1989-01-05 |
Smith Kline French Lab |
Chemical compounds
|
|
USRE36736E
(en)
*
|
1989-02-06 |
2000-06-13 |
Hoffman-La Roche Inc. |
Substituted pyrroles
|
|
GB8904161D0
(en)
*
|
1989-02-23 |
1989-04-05 |
Hoffmann La Roche |
Substituted pyrroles
|
|
MC2096A1
(fr)
|
1989-02-23 |
1991-02-15 |
Hoffmann La Roche |
Pyrroles substitues
|
|
US5380746A
(en)
*
|
1989-05-05 |
1995-01-10 |
Goedecke Aktiengesellschaft |
Bis-(1H-indol-3-YL)-maleinimide derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
|
|
CA2015996C
(en)
|
1989-05-05 |
2001-08-28 |
Hartmut Osswald |
Bis-(1h-indol-3-yl)-maleinimide derivatives and their use as pharmaceuticals
|
|
DE4005970A1
(de)
|
1990-02-26 |
1991-08-29 |
Boehringer Mannheim Gmbh |
Neue trisubstituierte maleinimide, verfahren zu ihrer herstellung sowie arzneimittel, die diese verbindungen enthalten
|
|
DE4005969A1
(de)
|
1990-02-26 |
1991-08-29 |
Boehringer Mannheim Gmbh |
Neue trisubstituierte pyrrole, verfahren zu ihrer herstellung sowie arzneimittel, die diese verbindungen enthalten
|
|
AU640016B2
(en)
*
|
1990-05-30 |
1993-08-12 |
Imperial Chemical Industries Plc |
Hydroquinazoline derivatives
|
|
US5292747A
(en)
*
|
1990-08-07 |
1994-03-08 |
Hoffman-La Roche Inc. |
Substituted pyrroles
|
|
US5591842A
(en)
*
|
1991-11-29 |
1997-01-07 |
Banyu Pharmaceutical Co., Ltd. |
Indolopyrrolocarbazole derivatives
|
|
HU219121B
(hu)
|
1992-03-12 |
2001-02-28 |
Smithkline Beecham Plc. |
Kondenzált indolszármazékok, eljárás előállításukra és ezeket tartalmazó 5-HT4-receptor antagonista hatású gyógyászati készítmények
|
|
JPH07504673A
(ja)
|
1992-03-20 |
1995-05-25 |
ザ・ウエルカム・ファウンデーション・リミテッド |
抗ウイルス活性を有するインドール誘導体
|
|
US5721230A
(en)
*
|
1993-05-10 |
1998-02-24 |
Hoffmann-La Roche Inc. |
Substituted pyrroles
|
|
EP1449529B1
(en)
|
1993-12-23 |
2010-01-27 |
Eli Lilly And Company |
Protein Kinase C Inhibitors
|
|
US5545636A
(en)
*
|
1993-12-23 |
1996-08-13 |
Eli Lilly And Company |
Protein kinase C inhibitors
|
|
US6524832B1
(en)
*
|
1994-02-04 |
2003-02-25 |
Arch Development Corporation |
DNA damaging agents in combination with tyrosine kinase inhibitors
|
|
AU2096895A
(en)
*
|
1994-03-07 |
1995-09-25 |
Sugen, Incorporated |
Receptor tyrosine kinase inhibitors for inhibiting cell proliferative disorders and compositions thereof
|
|
WO1995030682A1
(en)
|
1994-05-09 |
1995-11-16 |
Banyu Pharmaceutical Co., Ltd. |
Antitumor indolopyprolocarbazole derivative
|
|
IL110831A
(en)
|
1994-08-31 |
1998-12-27 |
Hadasit Med Res Service |
Pharmaceutical compositions containing quinazolinone derivatives for preventing restenosis
|
|
US5591855A
(en)
*
|
1994-10-14 |
1997-01-07 |
Cephalon, Inc. |
Fused pyrrolocarbazoles
|
|
IL112125A
(en)
|
1994-12-22 |
1998-02-08 |
Hadasit Med Res Service |
Quinazolinone-containing pharmaceutical compositions
|
|
US5559228A
(en)
*
|
1995-03-30 |
1996-09-24 |
Eli Lilly And Company |
Synthesis of bisindolylmaleimides
|
|
US5747498A
(en)
*
|
1996-05-28 |
1998-05-05 |
Pfizer Inc. |
Alkynyl and azido-substituted 4-anilinoquinazolines
|
|
JP3258334B2
(ja)
|
1996-03-20 |
2002-02-18 |
イーライ・リリー・アンド・カンパニー |
インドリルマレイミドの合成
|
|
PE91598A1
(es)
|
1996-07-29 |
1998-12-24 |
Hoffmann La Roche |
Pirroles sustituidos
|
|
PE91698A1
(es)
*
|
1996-07-29 |
1998-12-24 |
Hoffmann La Roche |
Pirroles sustituidos
|
|
WO1998007693A1
(en)
|
1996-08-23 |
1998-02-26 |
Eli Lilly And Company |
Synthesis of bisindolylmalimides
|
|
SE9603283D0
(sv)
*
|
1996-09-10 |
1996-09-10 |
Astra Ab |
New compounds
|
|
US6153618A
(en)
|
1996-10-11 |
2000-11-28 |
Chiron Corporation |
Inhibitors of glycogen synthase 3 kinase
|
|
US6028075A
(en)
|
1997-02-11 |
2000-02-22 |
Pines; Mark |
Quinazolinone containing pharmaceutical compositions for prevention of neovascularization and for treating malignancies
|
|
US5859261A
(en)
*
|
1997-03-20 |
1999-01-12 |
Eli Lilly And Company |
Synthesis of indolylmaleimides
|
|
US6184377B1
(en)
*
|
1997-12-15 |
2001-02-06 |
Sepracor Inc. |
Compositions containing N-amino- and N-hydroxy-quinazolinones and methods for preparing libraries thereof
|
|
CN1320123A
(zh)
|
1998-07-30 |
2001-10-31 |
日本烟草产业株式会社 |
二取代马来酰亚胺化合物及其医药用途
|
|
EP1152002A4
(en)
|
1999-02-09 |
2002-04-17 |
Sagami Chem Res |
PYRROL DERIVATIVES AND CELL DEATH INHIBITORS
|
|
US6545004B1
(en)
|
1999-10-27 |
2003-04-08 |
Cytokinetics, Inc. |
Methods and compositions utilizing quinazolinones
|
|
CA2388646C
(en)
|
1999-10-27 |
2009-01-27 |
Cytokinetics, Inc. |
Methods and compositions utilizing quinazolinones
|
|
UA74803C2
(uk)
*
|
1999-11-11 |
2006-02-15 |
Осі Фармасьютікалз, Інк. |
Стійкий поліморф гідрохлориду n-(3-етинілфеніл)-6,7-біс(2-метоксіетокси)-4-хіназолінаміну, спосіб його одержання (варіанти) та фармацевтичне застосування
|
|
EP1242420A2
(en)
|
1999-12-16 |
2002-09-25 |
Eli Lilly And Company |
Agents and methods for the treatment of proliferative diseases
|
|
ATE267194T1
(de)
|
1999-12-16 |
2004-06-15 |
Lilly Co Eli |
Medikamente geeignet zur behandlung von proliferativen erkrankungen
|
|
US20030087949A1
(en)
|
2000-03-30 |
2003-05-08 |
Mikiko Sodeoka |
Indolylpyrrole derivatives and cell death inhibitors
|
|
DE60129222T2
(de)
|
2000-05-11 |
2008-03-06 |
Consejo Superior de Investigaciónes Científicas |
Heterocyclischen inhibitoren von glycogen synthase kinase gsk-3
|
|
AU7785401A
(en)
|
2000-06-29 |
2002-01-14 |
Long Island Jewish Res Inst |
Modulators of cellular proliferation and angiogenesis, methods for use and identification thereof
|
|
US6962944B2
(en)
|
2001-07-31 |
2005-11-08 |
Arqule, Inc. |
Pharmaceutical compositions containing beta-lapachone, or derivatives or analogs thereof, and methods of using same
|
|
US7074824B2
(en)
|
2001-07-31 |
2006-07-11 |
Arqule, Inc. |
Pharmaceutical compositions containing beta-lapachone, or derivatives or analogs thereof, and methods of using same
|
|
JP2005511581A
(ja)
*
|
2001-11-07 |
2005-04-28 |
メルク エンド カムパニー インコーポレーテッド |
有糸分裂キネシン阻害剤
|
|
US6753428B2
(en)
|
2001-11-20 |
2004-06-22 |
Cytokinetics, Inc. |
Process for the racemization of chiral quinazolinones
|
|
CA2473853A1
(en)
|
2002-01-23 |
2003-08-14 |
J. Suzanne Lindsey |
Mammalian migration inducting gene and methods for detection and inhibition of migrating tumor cells
|
|
US7009049B2
(en)
|
2002-02-15 |
2006-03-07 |
Cytokinetics, Inc. |
Syntheses of quinazolinones
|
|
PT1483265E
(pt)
|
2002-03-05 |
2007-01-31 |
Lilly Co Eli |
Derivados de purina como inibidores de quinase
|
|
EP1553931A4
(en)
|
2002-05-09 |
2006-08-30 |
Cytokinetics Inc |
COMPOUNDS, COMPOSITIONS AND METHODS
|
|
US7038048B2
(en)
*
|
2002-05-23 |
2006-05-02 |
Cytokinetics, Inc. |
3H-pyridopyrimidin-4-one compounds, compositions, and methods of their use
|
|
JP2006506401A
(ja)
*
|
2002-05-23 |
2006-02-23 |
メルク エンド カムパニー インコーポレーテッド |
有糸分裂キネシン阻害薬
|
|
JP2006501201A
(ja)
*
|
2002-07-23 |
2006-01-12 |
サイトキネティクス・インコーポレーテッド |
化合物、組成物および方法
|
|
US20070059697A1
(en)
|
2003-04-15 |
2007-03-15 |
Avalon Pharmaceuticals, Inc |
Determining cancer-linked genes and therapeutic targets using molecular cytogenetic methods
|
|
US20050043233A1
(en)
|
2003-04-29 |
2005-02-24 |
Boehringer Ingelheim International Gmbh |
Combinations for the treatment of diseases involving cell proliferation, migration or apoptosis of myeloma cells or angiogenesis
|
|
EP1633758B1
(en)
|
2003-05-15 |
2011-11-23 |
Arqule, Inc. |
Imidazothiazoles and imidazoxazole derivatives as inhibitors of p38
|
|
US7345046B2
(en)
|
2003-05-30 |
2008-03-18 |
Chiron Corporation |
Heteroaryl-fused pyrimidinyl compounds as anticancer agents
|
|
KR101148657B1
(ko)
|
2003-06-06 |
2012-07-05 |
제넨테크, 인크. |
Hgf 베타 쇄와 c-met 사이의 상호작용의 변조
|
|
EP1648493B1
(en)
|
2003-07-07 |
2009-12-09 |
Van Andel Research Institute |
Inhibition of tumor angiogenesis by combination of thrombospondin-1 and inhibitors of vascular endothelial growth factor
|
|
CN1922208A
(zh)
|
2003-12-11 |
2007-02-28 |
健泰科生物技术公司 |
用于抑制c-met二聚化及活化的方法和组合物
|
|
US8178672B2
(en)
|
2004-10-19 |
2012-05-15 |
Arqule, Inc. |
Synthesis of imidazooxazole and imidazothiazole inhibitors of p38 MAP kinase
|
|
RU2409579C2
(ru)
|
2005-02-09 |
2011-01-20 |
Аркьюл, Инк. |
Композиции и способы лечения рака
|
|
TWI362940B
(en)
|
2005-03-31 |
2012-05-01 |
Gen Hospital Corp |
A use of agonist and/or antagonist of hgf/hgfr activity
|
|
WO2007123892A2
(en)
*
|
2006-04-17 |
2007-11-01 |
Arqule Inc. |
Raf inhibitors and their uses
|